NEW YORK, Aug. 27 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today lists the common stock of Neuralstem, Inc. under the ticker symbol CUR.
Neuralstem, Inc. is a biotechnology company focused on developing and commercializing human neural stem cell technology in the field of regenerative medicine.
"We proudly welcome Neuralstem to the American Stock Exchange," said John McGonegal, Senior Vice President of Amex's Equities Group. "Many biotechnology companies have chosen to list at the Amex this year and we are pleased that Neuralstem is the latest company to recognize our expanding presence in this important sector."
"Moving to the Amex is the next logical step for Neuralstem. It is a result of the continuous and significant progress the company has made in each and every phase of its activity, and of an increasing awareness of the company and its prospects on the part of the financial community," said Richard Garr, Neuralstem President and Chief Executive Officer.
The specialist for Neuralstem, Inc. will be Cohen Specialist LLC. For further information on CUR and other Amex-listed companies, please visit http://www.amex.com.
About American Stock Exchange
The American Stock Exchange(R) (Amex(R)) offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRS(SM). In addition to its role as a national equities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 337 ETFs to date. The Amex is also one of the largest options exchanges in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks. For more information, please visit http://www.amex.com
|SOURCE American Stock Exchange|
Copyright©2007 PR Newswire.
All rights reserved